Piper Sandler Cuts Amphastar Pharmaceuticals (NASDAQ:AMPH) Price Target to $32.00
Amphastar Pharmaceuticals (NASDAQ:AMPH – Free Report) had its price objective lowered by Piper Sandler from $36.00 to $32.00 in a report published on Friday,Benzinga reports. The firm currently has a neutral rating on the stock. Separately, Wells Fargo & Company started coverage on shares of Amphastar Pharmaceuticals in a report on Friday, November 22nd. They […]
Amphastar Pharmaceuticals (NASDAQ:AMPH – Free Report) had its price objective lowered by Piper Sandler from $36.00 to $32.00 in a report published on Friday,Benzinga reports. The firm currently has a neutral rating on the stock. Separately, Wells Fargo & Company started coverage on shares of Amphastar Pharmaceuticals in a report on Friday, November 22nd. They […]
